Case Studies
Representative R&D evidence packages. Each case illustrates how analytical outputs support translational and early-stage drug development decisions. Figures are generated from mock data for layout demonstration.
Tumor Neoantigen Prediction & Ranking
Which neoantigen candidates should be prioritized for early experimental validation under a limited peptide synthesis budget?
View case
Biomarker Screening & Diagnostic Model
Can a multi-marker panel stratify patient subgroups and provide sufficient evidence to support biomarker prioritization before larger validation investment?
View case
Single-Cell Transcriptomics Analysis
Which immune cell populations in the tumor microenvironment show consistent patterns that can guide mechanistic hypotheses and experimental prioritization?
View case
Mendelian Randomization Causal Analysis
Does genetic evidence support a causal relationship between a metabolic exposure and disease outcome strong enough to inform target prioritization?
View case